IP Library Granted Patent US 10,195,422
Granted Patent B2
US 10,195,422 · App. 14/846,648 · Granted Feb 5, 2019

Delivery system for cardiac pacing

Inventors: Rick Sanghera (San Clemente, CA); Alan Marcovecchio (San Clemente, CA); Sean McGeehan (Rancho Santa Fe, CA)
Assignee: AtaCor Medical, Inc.
A61N1/0592A61N1/0504A61N1/0587A61N1/362A61N1/365A61N1/3655A61N1/36542A61N1/36564A61N1/37211A61B17/3468A61B2017/3482A61B2017/3488A61B2017/3492A61M25/00A61M25/06A61M2205/587A61N1/059A61N1/3752
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,195,422
App. No.
14/846,648
Granted
Feb 5, 2019
Kind
B2
Abstract

A delivery device for installing a medical device in a patient comprising a body portion having a proximal end and a distal end, the distal end having a chisel shaped tip, a receptacle disposed in the distal end of the body portion for receiving a medical device for implanting in the patient, a handle disposed at the proximal end of the body portion for facilitating advancement of the proximal end of the body portion into the patient.

Claims (41)

1. A cardiac pacing system comprising:

a pulse generator including a housing, the pulse generator configured to generate therapeutic electric pulses;

at least one lead configured to electrically couple with the pulse generator and transmit the therapeutic electric pulses generated by the pulse generator, the at least one lead comprising:

a lead body configured to transmit the therapeutic electric pulses between a distal end and a proximal end of the lead body;

an electrode to transmit the therapeutic electric pulses to a heart; and

at least one sensor disposed at the distal end of the lead body, the at least one sensor configured to monitor physiological characteristics of a patient when the distal end of the lead is advanced through an intercostal space associated with a cardiac notch of the left lung of the patient; and

an inflatable balloon disposed at a distal tip of the lead body, extending at least partially beyond the distal tip.

2. The cardiac pacing system as in claim 1 , wherein the at least one sensor comprises:

at least one accelerometer, the at least one accelerometer configured to detect movement of the distal end of the lead body as it is advanced into the patient.

3. The cardiac pacing system as in claim 2 , wherein the at least one accelerometer is configured to measure a pressure wave emitted by a blood-filled vessel of the patient.

4. The cardiac pacing system as in claim 1 , wherein the at least one sensor comprises:

a light source configured to emit photons having a wavelength that is readily absorbed by blood-filled structures; and,

a light detector configured to detect photons reflected by tissue surrounding the blood-filled structures of the patient.

5. The cardiac pacing system as in claim 1 , wherein the at least one sensor comprises a thermocouple configured to monitor temperature of tissue in a vicinity of the distal end of the lead to facilitate a determination of a depth of the distal end of the lead in the patient.

6. The cardiac pacing system as in claim 1 , wherein the at least one sensor comprises a pH meter configured to monitor the pH level of tissue in a vicinity of the distal end of the lead to facilitate a determination of a depth of the distal end of the lead in the patient.

7. The cardiac pacing system as in claim 1 , wherein the at least one sensor comprises an electrical impedance sensor configured to monitor the level of electrical impedance of tissue in a vicinity of the distal end of the lead to facilitate a determination of a depth of the distal end of the lead in the patient.

8. The cardiac pacing system as in claim 1 , wherein the inflatable balloon is configured to be inflated to separate the distal end of the lead body from physiological elements of the patient.

9. The cardiac pacing system as in claim 8 , wherein the inflatable balloon facilitates avoidance of perforation of the physiological elements of the patient by the distal end of the lead body.

10. The cardiac pacing system as in claim 1 , wherein the inflatable balloon is configured to inflate transversely from the lead body to displace the lead body from physiological elements of the patient.

11. The cardiac pacing system as in claim 1 , wherein the inflatable balloon extends at least partially beyond the electrode.

12. The cardiac pacing system as in claim 1 , wherein the inflatable balloon is configured to be inflated to displace soft tissue elements of the patient during advancement of the distal end of the lead body through the patient.

13. A cardiac pacing system comprising:

a pulse generator including a housing, the pulse generator configured to generate therapeutic electric pulses;

at least one lead configured to electrically couple with the pulse generator and transmit the therapeutic electric pulses generated by the pulse generator, the at least one lead comprising:

a lead body configured to transmit the therapeutic electric pulses between a distal end and a proximal end of the lead body;

an electrode to transmit the therapeutic electric pulses to a heart; and

at least one sensor disposed at the distal end of the lead body, the at least one sensor configured to monitor physiological characteristics of a patient when the distal end of the lead body is advanced into the patient; and

an inflatable balloon extending at least partially beyond the electrode and a distal tip of the lead body.

14. The cardiac pacing system as in claim 13 , wherein the at least one sensor comprises:

at least one accelerometer, the at least one accelerometer configured to detect movement of the distal end of the lead body as it is advanced into the patient.

15. The cardiac pacing system as in claim 14 , wherein the at least one accelerometer is configured to measure a pressure wave emitted by a blood-filled vessel of the patient.

16. The cardiac pacing system as in claim 13 , wherein the at least one sensor comprises:

a light source configured to emit photons having a wavelength that is readily absorbed by blood-filled structures; and,

a light detector configured to detect photons reflected by tissue surrounding the blood-filled structures of the patient.

17. The cardiac pacing system as in claim 13 , wherein the at least one sensor comprises a thermocouple configured to monitor a temperature of tissue in a vicinity of the distal end of the lead to facilitate a determination of a depth of the distal end of the lead in the patient.

18. The cardiac pacing system as in claim 13 , wherein the at least one sensor comprises a pH meter configured to monitor the pH level of tissue in a vicinity of the distal end of the lead to facilitate a determination of a depth of the distal end of the lead in the patient.

19. The cardiac pacing system as in claim 13 , wherein the at least one sensor comprises an electrical impedance sensor configured to monitor the level of electrical impedance of tissue in a vicinity of the distal end of the lead to facilitate a determination of a depth of the distal end of the lead in the patient.

20. The cardiac pacing system as in claim 13 , wherein the inflatable balloon is configured to be inflated to separate the distal end of the lead body from physiological elements of the patient.

21. The cardiac pacing system as in claim 20 , wherein the inflatable balloon facilitates avoidance of perforation of the physiological elements of the patient by the distal end of the lead body.

22. The cardiac pacing system as in claim 13 , wherein the inflatable balloon is configured to inflate transversely from the lead body to displace the lead body from physiological elements of the patient.

23. The cardiac pacing system as in claim 13 , wherein the inflatable balloon is configured to be inflated to displace soft tissue elements of the patient during advancement of the distal end of the lead body through the patient.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 4, 2015
From: SANGHERA, RICK; MARCOVECCHIO, ALAN; MC GEEHAN, SEAN
To: ATACOR MEDICAL, INC.
Reel/Frame 036499/0616 →
Continuity (4)
Provisional Application 62146569 · Apr 13, 2015
Provisional Application 62083516 · Nov 24, 2014
Provisional Application 62045683 · Sep 4, 2014
Related Publication 20160067480A1 · Mar 10, 2016